Home/Duke Street Bio/Dr. Alan Wise
DA

Dr. Alan Wise

Chief Executive Officer

Duke Street Bio

Therapeutic Areas

Duke Street Bio Pipeline

DrugIndicationPhase
DSB2455Advanced Malignancies (with DDR deficiencies)Phase 1a/1b